Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.

NCT: NCT07337538 · ACTIVE_NOT_RECRUITING

NCT IDNCT07337538
StatusACTIVE_NOT_RECRUITING
Start Date2026-01-14
Completion2026-11-03
SponsorUniversity of Baghdad (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are: which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate. 20 participant will receive 40 mini implant bilaterally (20 in one side of 1.6mm, the other side 20 of 2mm). participants will be asked to record visual analog scale (VAS) for 3 nights monitored monthly by the investigator.

Frequently Asked Questions

What is Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.?

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region. is a clinical trial registered under NCT07337538. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07337538?

The current status of NCT07337538 (Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.) is: ACTIVE_NOT_RECRUITING.

When did Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region. start?

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region. started on 2026-01-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.